Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions
Open Access
- 31 July 2018
- journal article
- review article
- Published by Oxford University Press (OUP) in Stem Cells Translational Medicine
- Vol. 7 (9), 676-685
- https://doi.org/10.1002/sctm.17-0282
Abstract
The promise of stem cell (SC) therapies to restore functions of damaged tissues and organs brings enormous hope to patients, their families, loved ones, and caregivers. However, limits may exist for which indications SC therapies might be useful, efficacious, and safe. Applications of innovative therapies within regulatory boundaries and within the framework of controlled clinical trials are the norm in the scientific and medical community; such a system minimizes patient risk by setting a clear and acceptable safety and efficacy profile for new therapeutics before marketing authorization. This careful clinical validation approach often takes time, which patients suffering from terminal or debilitating diseases do not have. Not validated, unproven stem cell interventions (SCI) that promise a working treatment or cure for severe diseases have therefore found their way into the patient community, and providers of such treatments often take advantage of the public's willingness to pay large amounts of money for the misguided hope of a reliable recovery from their illnesses. We conducted a review of scientific publications, clinical case reports, and mass media publications to assess the reported cases and safety incidents associated with unproven SCI. The review also analyzes the main factors that were identified as contributing to the emergence and global rise of the “stem cell tourism” phenomenon. Stem Cells Translational Medicine 2018;1–10Keywords
This publication has 78 references indexed in Scilit:
- The Promise and Perils of Stem Cell TherapeuticsCell Stem Cell, 2012
- Stem‐cell tourism and scientific responsibilityEMBO Reports, 2011
- Stem cells in clinical practice: applications and warningsJournal of Experimental & Clinical Cancer Research, 2011
- Ventricular fibrillation following autologous intramyocardial cell therapy for inherited cardiomyopathyCardiovascular Pathology, 2010
- The therapeutic potential of stem cellsPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2010
- Technical Challenges in Using Human Induced Pluripotent Stem Cells to Model DiseaseCell Stem Cell, 2009
- Mesenchymal stromal cellsCurrent Opinion in Hematology, 2006
- Dutch clinic is ordered to stop giving stem cell therapyBMJ, 2006
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Embryonic Stem Cell Lines Derived from Human BlastocystsScience, 1998